Literature DB >> 22633363

Mapping of pain phenotypes in female patients with bladder pain syndrome/interstitial cystitis and controls.

Dean A Tripp1, J Curtis Nickel, Jennifer Wong, Michel Pontari, Robert Moldwin, Robert Mayer, Lesley K Carr, Ragi Doggweiler, Claire C Yang, Nagendra Mishra, Jorgen Nordling.   

Abstract

BACKGROUND: Many bladder pain syndrome/interstitial cystitis (BPS/IC) patients report multiple pain locations outside the pelvis. No research has examined pain using a whole-body diagram, pain-associated adjustment factors, or the impact of pain in multiple body areas on patients' quality of life (QoL).
OBJECTIVE: Compare and contrast pain in BPS/IC patients and controls using a whole-body diagram (visible body areas). Examine the association between patient adjustment factors and greater number of body pain areas (pain phenotypes). DESIGN, SETTING, AND PARTICIPANTS: Validated questionnaires were collected from diagnosed, tertiary-care, outpatient, female BPS/IC patients (n=193) and age-matched controls (n=115). Scales included a body pain area diagram, demographics/history, pain severity, BPS/IC symptoms, pain, depression, catastrophizing, and QoL. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Cross-tabulation and analysis of variance models addressed the patient and control differences. RESULTS AND LIMITATIONS: Patients reported more pain than controls in all reported body areas. Four pain phenotypes were created based on increasing counts of body locations (BPS/IC only, BPS/IC+plus 1-3 additional locations, BPS/IC plus 4-9, BPS/IC ≥ 10). Patients reported more body pain locations, pain, urinary symptoms, depression, catastrophizing, and diminished QoL than controls. The increased-pain phenotype was associated with poorer psychosocial adjustment and diminished physical QoL, but catastrophizing and low scores for mental QoL remained stable across all patient groups. This study was cross-sectional, relying on correlation-based analyses, thus causality cannot be established.
CONCLUSIONS: Patients reported numerous systemic pain symptoms outside the areas associated with the bladder/pelvic region, and increased numbers of body pain sites were associated with poorer patient outcomes (ie, pain severity, depression). This study illustrates the significant negative impact of pain on patient adjustment in BPS/IC. These findings suggest that clinicians carefully consider pain location distributions and the potential impact of body pain phenotypes during patient evaluation and treatment planning.
Copyright © 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22633363     DOI: 10.1016/j.eururo.2012.05.023

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  30 in total

1.  Adverse Childhood Experiences and Symptoms of Urologic Chronic Pelvic Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Study.

Authors:  Andrew Schrepf; Bruce Naliboff; David A Williams; Alisa J Stephens-Shields; J Richard Landis; Arpana Gupta; Emeran Mayer; Larissa V Rodriguez; Henry Lai; Yi Luo; Catherine Bradley; Karl Kreder; Susan K Lutgendorf
Journal:  Ann Behav Med       Date:  2018-09-13

2.  Depression and helplessness impact interstitial cystitis/bladder pain syndrome pain over time.

Authors:  Alison Crawford; Dean A Tripp; J Curtis Nickel; Lesley Carr; Robert Moldwin; Laura Katz; Abi Muere
Journal:  Can Urol Assoc J       Date:  2019-10       Impact factor: 1.862

3.  Sensory mapping of pelvic dermatomes in women with interstitial cystitis/bladder pain syndrome.

Authors:  Tatiana Sanses; Patrick McCabe; Ling Zhong; Aisha Taylor; Gisela Chelimsky; Sangeeta Mahajan; Tony Buffington; Adonis Hijaz; Sarah Ialacci; Jeffrey Janata; Thomas Chelimsky
Journal:  Neurourol Urodyn       Date:  2017-06-19       Impact factor: 2.696

Review 4.  Evaluation of the female with chronic urologic pain.

Authors:  Lesley K Carr
Journal:  Can Urol Assoc J       Date:  2018-06       Impact factor: 1.862

5.  A directional preference approach for chronic pelvic pain, bladder dysfunction and concurrent musculoskeletal symptoms: a case series.

Authors:  Christine Hughes; Stephen May
Journal:  J Man Manip Ther       Date:  2019-11-08

6.  Depression and catastrophizing predict suicidal ideation in tertiary care patients with interstitial cystitis/bladder pain syndrome.

Authors:  Dean A Tripp; J Curtis Nickel; Adrijana Krsmanovic; Michel Pontari; Robert Moldwin; Robert Mayer; Lesley K Carr; Claire C Yang; Jorgen Nordling
Journal:  Can Urol Assoc J       Date:  2016 Nov-Dec       Impact factor: 1.862

7.  Important role of physicians in addressing psychological aspects of interstitial cystitis/bladder pain syndrome (IC/BPS): a qualitative analysis.

Authors:  Gregory Kanter; Katherine A Volpe; Gena C Dunivan; Sara B Cichowski; Peter C Jeppson; Rebecca G Rogers; Yuko M Komesu
Journal:  Int Urogynecol J       Date:  2016-08-31       Impact factor: 2.894

8.  Psychosocial co-morbidities in Interstitial Cystitis/Bladder Pain syndrome (IC/BPS): A systematic review.

Authors:  Lindsey C McKernan; Colin G Walsh; William S Reynolds; Leslie J Crofford; Roger R Dmochowski; David A Williams
Journal:  Neurourol Urodyn       Date:  2017-10-09       Impact factor: 2.696

9.  Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.

Authors:  Bruce D Naliboff; Alisa J Stephens; H Henry Lai; James W Griffith; J Quentin Clemens; Susan Lutgendorf; Larissa V Rodriguez; Craig Newcomb; Siobhan Sutcliffe; Wensheng Guo; John W Kusek; J Richard Landis
Journal:  J Urol       Date:  2017-05-18       Impact factor: 7.450

10.  Characterization of Whole Body Pain in Urological Chronic Pelvic Pain Syndrome at Baseline: A MAPP Research Network Study.

Authors:  H Henry Lai; Thomas Jemielita; Siobhan Sutcliffe; Catherine S Bradley; Bruce Naliboff; David A Williams; Robert W Gereau; Karl Kreder; J Quentin Clemens; Larissa V Rodriguez; John N Krieger; John T Farrar; Nancy Robinson; J Richard Landis
Journal:  J Urol       Date:  2017-03-31       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.